Exelixis

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.

About EXEL

Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of COMETRIQ, CABOMETYX, COTELLIC, and MINNEBRO.

CEO

Michael M. Morrissey

CEOMichael M. Morrissey

Employees

954

Employees954

Headquarters

Alameda, California

HeadquartersAlameda, California

Founded

1994

Founded1994

Employees

954

Employees954

EXEL Key Statistics

Market cap

5.27B

Market cap5.27B

Price-Earnings ratio

17.56

Price-Earnings ratio17.56

Dividend yield

—

Dividend yield—

Average volume

1.55M

Average volume1.55M

High today

$16.75

High today$16.75

Low today

$16.16

Low today$16.16

Open price

$16.66

Open price$16.66

Volume

1.85M

Volume1.85M

52 Week high

$23.40

52 Week high$23.40

52 Week low

$14.87

52 Week low$14.87

EXEL News

Yahoo Finance 7d

Why Is Exelixis Up 0.4% Since Last Earnings Report? - Yahoo Finance

It has been about a month since the last earnings report for Exelixis (EXEL). Shares have added about 0.4% in that time frame, underperforming the S&P 500. Wil...

Analyst ratings

81%

of 16 ratings

Buy

81.3%

Hold

12.5%

Sell

6.3%

EXEL Earnings

$0.00

$0.12

$0.25

$0.37

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Feb 16, After Hours

ActualExpected Feb 16, After Hours